WO2016186349A3 - 사군자 추출물을 함유하는 전립선 비대증 예방 또는 치료용 조성물 - Google Patents
사군자 추출물을 함유하는 전립선 비대증 예방 또는 치료용 조성물 Download PDFInfo
- Publication number
- WO2016186349A3 WO2016186349A3 PCT/KR2016/004653 KR2016004653W WO2016186349A3 WO 2016186349 A3 WO2016186349 A3 WO 2016186349A3 KR 2016004653 W KR2016004653 W KR 2016004653W WO 2016186349 A3 WO2016186349 A3 WO 2016186349A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- prostatic hyperplasia
- quisaqualis
- preventing
- composition
- indica extract
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
Abstract
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201680029207.9A CN107635572A (zh) | 2015-05-18 | 2016-05-03 | 包含使君子提取物的用于预防或治疗前列腺增生的组合物 |
US15/574,702 US20180153949A1 (en) | 2015-05-18 | 2016-05-03 | Composition, containing quisaqualis indica extract, for preventing or treating prostatic hyperplasia |
ES16796676T ES2770979T3 (es) | 2015-05-18 | 2016-05-03 | Composición que contiene Quisqualis indica |
JP2017560230A JP6773303B2 (ja) | 2015-05-18 | 2016-05-03 | シクンシ抽出物を含む前立腺肥大症の予防または治療用組成物 |
EP16796676.1A EP3299025B1 (en) | 2015-05-18 | 2016-05-03 | Composition containing quisqualis indica |
MYPI2017704390A MY195068A (en) | 2015-05-18 | 2016-05-03 | Compositions for Preventing or Treating Benign Prostatic Hyperplasia Comprising Extracts of Quisqualis Indica |
PH12017502081A PH12017502081B1 (en) | 2015-05-18 | 2017-11-16 | Composition, containing quisqualis indica extract, for preventing or treating prostatic hyperplasia |
US16/725,608 US11771726B2 (en) | 2015-05-18 | 2019-12-23 | Composition, containing Quisqualis indica extract, for preventing or treating prostatic hyperplasia |
US18/058,038 US20230082624A1 (en) | 2015-05-18 | 2022-11-22 | Composition, containing quisqualis indica extract, for preventing or treating prostatic hyperplasia |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2015-0069047 | 2015-05-18 | ||
KR1020150069047A KR101552813B1 (ko) | 2015-05-18 | 2015-05-18 | 사군자 추출물을 함유하는 전립선 비대증 예방 또는 치료용 조성물 |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/574,702 A-371-Of-International US20180153949A1 (en) | 2015-05-18 | 2016-05-03 | Composition, containing quisaqualis indica extract, for preventing or treating prostatic hyperplasia |
US16/725,608 Division US11771726B2 (en) | 2015-05-18 | 2019-12-23 | Composition, containing Quisqualis indica extract, for preventing or treating prostatic hyperplasia |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2016186349A2 WO2016186349A2 (ko) | 2016-11-24 |
WO2016186349A3 true WO2016186349A3 (ko) | 2017-01-12 |
Family
ID=54248172
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2016/004653 WO2016186349A2 (ko) | 2015-05-18 | 2016-05-03 | 사군자 추출물을 함유하는 전립선 비대증 예방 또는 치료용 조성물 |
Country Status (9)
Country | Link |
---|---|
US (3) | US20180153949A1 (ko) |
EP (1) | EP3299025B1 (ko) |
JP (1) | JP6773303B2 (ko) |
KR (1) | KR101552813B1 (ko) |
CN (1) | CN107635572A (ko) |
ES (1) | ES2770979T3 (ko) |
MY (1) | MY195068A (ko) |
PH (1) | PH12017502081B1 (ko) |
WO (1) | WO2016186349A2 (ko) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101552813B1 (ko) * | 2015-05-18 | 2015-09-11 | 충남대학교산학협력단 | 사군자 추출물을 함유하는 전립선 비대증 예방 또는 치료용 조성물 |
KR20190090910A (ko) | 2018-01-26 | 2019-08-05 | 최윤식 | 나노화된 꿀벌 화분을 유효성분으로 포함하는 양성 전립선 비대증 개선용 조성물 |
KR102293358B1 (ko) * | 2018-12-06 | 2021-08-24 | (주)휴온스 | 사군자 초임계 추출물을 함유하는 전립선 비대증 예방 또는 치료용 조성물 |
CN112891350B (zh) * | 2021-04-02 | 2022-09-27 | 宁夏医科大学 | 胡芦巴碱在制备预防或治疗前列腺增生药物中的应用 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3176983B2 (ja) * | 1992-04-27 | 2001-06-18 | 御木本製薬株式会社 | 美白化粧料 |
JP2003040769A (ja) * | 2001-07-26 | 2003-02-13 | Noevir Co Ltd | 皮膚外用剤 |
KR20130013712A (ko) * | 2011-07-28 | 2013-02-06 | 이승준 | 생약추출물을 포함하는 동물의 설사병 예방 및 치료용 약제학적 조성물 및 그의 제조방법 |
KR20140107614A (ko) * | 2011-12-27 | 2014-09-04 | 모리시타 진탄 가부시키가이샤 | 메일라드 반응 저해제 |
CN104171635A (zh) * | 2014-07-21 | 2014-12-03 | 宁国市百惠牧业有限公司 | 一种助消化中草药膳食猪饲料 |
KR20150048495A (ko) * | 2013-10-28 | 2015-05-07 | 양갑식 | 육종용 추출물을 유효성분으로 함유하는 전립선 비대증 예방 및 치료용 약학적 조성물 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4377584A (en) | 1978-04-13 | 1983-03-22 | Merck & Co., Inc. | 4-Aza-17β-substituted-5α-androstan-3-one-reductase inhibitors |
US4760071A (en) | 1984-02-27 | 1988-07-26 | Merck & Co., Inc. | 17β-N-monosubstituted carbamoyl-4-aza-5α-androst-1-en-3-ones which are active as testosterone 5α-reductase inhibitors |
US6211198B1 (en) * | 1993-04-05 | 2001-04-03 | Synaptic Pharmaceutical Corporation | Dihydropyridines and new uses thereof |
US6011021A (en) * | 1996-06-17 | 2000-01-04 | Guilford Pharmaceuticals Inc. | Methods of cancer treatment using naaladase inhibitors |
JP2002515040A (ja) | 1996-06-17 | 2002-05-21 | ギルフォード・ファーマシューティカルズ・インコーポレイテッド | Naaladアーゼ阻害剤を用いる癌治療方法 |
US8168234B2 (en) * | 2001-06-20 | 2012-05-01 | Metaproteomics, Llc | Compositions that treat or inhibit pathological conditions associated with inflammatory response |
KR100503193B1 (ko) | 2002-08-19 | 2005-07-25 | 한미약품 주식회사 | 3-옥소-4-아자-5α-안드로스탄 화합물의 선택적인 제조방법 |
JP2006199609A (ja) | 2005-01-19 | 2006-08-03 | Kao Corp | チモシンβ10発現増強剤 |
CN100525783C (zh) * | 2006-05-31 | 2009-08-12 | 暨南大学 | 使君子或其提取物在制备促进排铅作用中药制剂中的应用 |
CN102028789A (zh) * | 2010-12-31 | 2011-04-27 | 江西百神药业集团有限公司 | 一种小儿化积贴剂 |
CN103479978B (zh) * | 2013-09-18 | 2015-08-19 | 冯日生 | 一种驱蛔的中药组合物及其制备方法 |
CN104586664B (zh) * | 2013-10-31 | 2017-12-12 | 广州市纳爱生物科技有限公司 | 一种美白祛斑乳液 |
KR101552813B1 (ko) * | 2015-05-18 | 2015-09-11 | 충남대학교산학협력단 | 사군자 추출물을 함유하는 전립선 비대증 예방 또는 치료용 조성물 |
-
2015
- 2015-05-18 KR KR1020150069047A patent/KR101552813B1/ko active IP Right Grant
-
2016
- 2016-05-03 ES ES16796676T patent/ES2770979T3/es active Active
- 2016-05-03 MY MYPI2017704390A patent/MY195068A/en unknown
- 2016-05-03 JP JP2017560230A patent/JP6773303B2/ja active Active
- 2016-05-03 CN CN201680029207.9A patent/CN107635572A/zh active Pending
- 2016-05-03 WO PCT/KR2016/004653 patent/WO2016186349A2/ko active Application Filing
- 2016-05-03 EP EP16796676.1A patent/EP3299025B1/en active Active
- 2016-05-03 US US15/574,702 patent/US20180153949A1/en not_active Abandoned
-
2017
- 2017-11-16 PH PH12017502081A patent/PH12017502081B1/en unknown
-
2019
- 2019-12-23 US US16/725,608 patent/US11771726B2/en active Active
-
2022
- 2022-11-22 US US18/058,038 patent/US20230082624A1/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3176983B2 (ja) * | 1992-04-27 | 2001-06-18 | 御木本製薬株式会社 | 美白化粧料 |
JP2003040769A (ja) * | 2001-07-26 | 2003-02-13 | Noevir Co Ltd | 皮膚外用剤 |
KR20130013712A (ko) * | 2011-07-28 | 2013-02-06 | 이승준 | 생약추출물을 포함하는 동물의 설사병 예방 및 치료용 약제학적 조성물 및 그의 제조방법 |
KR20140107614A (ko) * | 2011-12-27 | 2014-09-04 | 모리시타 진탄 가부시키가이샤 | 메일라드 반응 저해제 |
KR20150048495A (ko) * | 2013-10-28 | 2015-05-07 | 양갑식 | 육종용 추출물을 유효성분으로 함유하는 전립선 비대증 예방 및 치료용 약학적 조성물 |
CN104171635A (zh) * | 2014-07-21 | 2014-12-03 | 宁国市百惠牧业有限公司 | 一种助消化中草药膳食猪饲料 |
Also Published As
Publication number | Publication date |
---|---|
US20180153949A1 (en) | 2018-06-07 |
EP3299025A4 (en) | 2019-01-09 |
US20200138886A1 (en) | 2020-05-07 |
JP6773303B2 (ja) | 2020-10-21 |
US11771726B2 (en) | 2023-10-03 |
MY195068A (en) | 2023-01-06 |
EP3299025A2 (en) | 2018-03-28 |
CN107635572A (zh) | 2018-01-26 |
ES2770979T3 (es) | 2020-07-06 |
PH12017502081A1 (en) | 2018-05-07 |
US20230082624A1 (en) | 2023-03-16 |
PH12017502081B1 (en) | 2018-05-07 |
KR101552813B1 (ko) | 2015-09-11 |
EP3299025B1 (en) | 2019-11-27 |
JP2018521003A (ja) | 2018-08-02 |
WO2016186349A2 (ko) | 2016-11-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2017100063A3 (en) | Stable ready-to-drink beverage compositions comprising lipophilic active agents | |
NZ742208A (en) | Topical pharmaceutical formulations for treating inflammatory-related conditions | |
WO2015013635A3 (en) | Inhibitors of transcription factors and uses thereof | |
WO2014188276A3 (en) | Antioxidant compositions and methods of using the same | |
WO2015077503A8 (en) | Autotaxin inhibitor compounds | |
WO2016004305A3 (en) | Inhibitors of bruton's tyrosine kinase | |
NZ712270A (en) | Pharmaceutical composition of s-ketamine hydrochloride | |
NZ628294A (en) | Compositions and methods of use of phorbol esters for the treatment of stroke | |
PH12017502081A1 (en) | Composition, containing quisqualis indica extract, for preventing or treating prostatic hyperplasia | |
WO2013134407A3 (en) | Procaspase 3 activation by combination therapy | |
PH12017500706A1 (en) | Composition containing extract or fraction of genus justicia plant | |
WO2012157978A3 (ko) | 팥꽃나무 추출물, 이의 분획물 또는 이로부터 분리한 화합물을 유효성분으로 함유하는 아토피 예방 또는 치료용 약학적 조성물 | |
MX2016015092A (es) | Inhibidor de proliferacion de celulas madre cancerosas. | |
PH12016501371A1 (en) | Pharmaceutical compositions comprising 15-hepe and methods of treating asthma and lung disorders using same | |
WO2014121137A3 (en) | Compositions and methods for the treatment of neurodegenerative and other diseases | |
MX2017011018A (es) | Inhibicion de la actividad de olig2. | |
WO2016073771A3 (en) | Pyrrolopyrimidine derivatives as mps1/ttk kinase inhibitors | |
WO2011149301A3 (en) | A composition comprising the extract of physalis alkekengi var. francheti hort as an active ingredient for preventing and treating inflammatory diseases | |
ZA201901367B (en) | Inhibition of olig2 activity | |
PH12016502544A1 (en) | Pharmaceutical preparation containing entecavir as active ingredient, and preparation method therefor | |
NZ701133A (en) | Composition for treating metabolic disorders | |
WO2016108572A3 (ko) | 콜레스테롤 관련 질환의 예방 및 치료용 조성물 | |
EP3144005A4 (en) | Composition for preventing and treating male infertility, containing mixed herbal extract as active ingredient and use thereof | |
MX2018014790A (es) | Formulacion combinada de tres compuestos antivirales. | |
WO2016030899A8 (en) | Methods of treating amyotrophic lateral scleroses |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 16796676 Country of ref document: EP Kind code of ref document: A2 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12017502081 Country of ref document: PH Ref document number: 15574702 Country of ref document: US |
|
ENP | Entry into the national phase |
Ref document number: 2017560230 Country of ref document: JP Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2016796676 Country of ref document: EP |